Snap Bio and i2020 Accelerator (Torrey Pines Investment) Reach Lead Compounds Milestone for Pediatric Oncology and Advanced Liver Cancer Programs

Read also

Gossamer Bio

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Amgen opens new drug substance

Amgen opens new drug substance facility in North Carolina, US

BIA report

BIA report: UK biotech investment surged to £3.5bn in 2024

MSD wins FDA

MSD wins FDA priority review for Welireg in rare endocrine cancer